Galvanize Therapeutics Raises $130 Million in Oversubscribed Series D Financing to Accelerate Commercial Growth and Advance PEF Innovation
<p>HealthQuest Capital leads financing to support Aliya commercial expansion, clinical evidence generation, pipeline advancement, and development of next-generation pulsed electric field ablation platforms REDWOOD CITY, Calif., Nov. 16, 2026 /PRNewswire/ -- Galvanize Therapeutics®, a...</p>
Read original article ↗